Policy. Capital. Science. Industry. One Destination

Spanning government dialogue, global exhibition, investment forums and scientific exchange, BioPharma Vietnam operates at the intersection of policy, capital and industry - where the decisions shaping Asia’s pharmaceutical future are made.

As Asia’s pharmaceutical supply chains diversify and Vietnam emerges as
the region’s preferred manufacturing destination, BioPharma Vietnam brings the full global value chain together — from APIs and CDMOs to biologics, advanced therapies and digital manufacturing systems.

Alongside the global exhibition, dedicated Partnership & Investment Meetings connect global manufacturers, sovereign investors and technology partners with Vietnam’s industrial strategy - facilitating the technology transfers, market entry decisions and capital commitments that define the region’s pharmaceutical decade.

BOOK YOUR STAND

DOWNLOAD EVENT BROCHURE

Top Reasons To Exhibit

Exhibiting at BioPharma Vietnam is a direct line to Asia's most consequential pharmaceutical decisions—accelerating market entry, securing strategic partnerships and positioning your organisation at the forefront of the region's most significant life sciences transformation.

Influence Asia's Pharmaceutical Future

If you are advancing pharmaceutical manufacturing, biotechnology, regulatory excellence, production technologies or supply chain capability, BioPharma Vietnam places your expertise alongside the pharmaceutical executives, government authorities, regulators, procurement leaders and investors shaping the region's next phase of growth.

Reach the Organisations Investing in Growth

Whether you provide manufacturing technologies, scientific expertise, advanced therapies or production capabilities, BioPharma Vietnam provides access to the organisations investing in pharmaceutical production, biotechnology innovation and resilient supply chains across Asia.

Secure Your Place in Asia's Pharmaceutical Decade

Market expansion, technology transfer, investment opportunities and long-term commercial partnerships come together in one platform, creating opportunities across pharmaceutical manufacturing, biotechnology innovation and Asia's evolving life sciences economy.